Litcius/Paper detail

Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes

Zowi R. Huinen, Elisabeth J. M. Huijbers, Judy R. van Beijnum, Patrycja Nowak‐Sliwinska, Arjan W. Griffioen

2021Nature Reviews Clinical Oncology413 citationsDOI

Topics & Concepts

MedicineAngiogenesisImmunotherapyImmune systemImmunologyClinical trialImmunityImmune checkpointCancer researchInternal medicineAngiogenesis and VEGF in CancerVascular Tumors and AngiosarcomasCancer Immunotherapy and Biomarkers
Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes | Litcius